• 2
  • html slider
  • 4
1 22 33 44
css image gallery by WOWSlider.com v8.8
Invited Speakers
MasterClass in Vaccinology 2020 program committee will provide multiple programs to achieve multi-disciplinary, multi-cultural solutions to help solve infectious medicine challenges at both the global and local levels. The committee will invite over 30 speakers to reach the objective of MasterClass in Vaccinology 2020 as following
  • Introduce basic knowledge in vaccinology.
  • Update the advance and the development in vaccinology, especially with regards to new vaccines.
  • Review data on the vaccine impact, effectiveness, and safety data in the real world.
  • Discuss on vaccination policies, including issues about vaccine hesitancy.
Speaker List:
September 5 | 08:30-09:10
Keynote Speech
Moderator Tzou-Yien Lin (Taiwan)
08:30-09:10 Vaccines for cancer prevention
Chien-Jen Chen
Vice President of Taiwan
TAIWAN
September 5 | 09:10-10:30
Plenary Session
Moderator Fu-Yuan Huang (Taiwan)
09:10-09:50 Emerging issues in vaccination
Kim Mulholland
Senior Principle Fellow and Group Leader, Murdoch Children’s Research Institute, Melbourne
Professor of International Child Health, Menzies School of Health Research, Darwin
Professor of Child Health and Vaccinology, London School of Hygiene and Tropical Medicine
AUSTRALIA
09:50 -10:30 Dengue vaccines: how do we get to the finish line?
Anna P. Durbin
Professor, Department of International Health, Johns
Hopkins Bloomberg School of Public Health
USA
September 5 | 10:50-12:35
Session 1: Basic Vaccinology
Moderator Juhani Eskola (Finland)
Moderator Kao-Pin Hwang (Taiwan)
10:50 -11:20 Basic concepts of vaccination
Yhu-Chering Huang
Professor, Chang Gung Memorial Hospital
TAIWAN



11:25 -11:55 Safety issues of vaccination
Ping-Ing Lee
Professor, Department of Pediatrics, National Taiwan University Children’s Hospital
TAIWAN


12:00 -12:30 Vaccine hesitancy
Juhani Eskola
National Institute of Health and Welfare
FINLAND



September 5 | 14:00 – 15:30
Session 2A: Rotavirus vaccines
Moderator Tony Nelson (Hong Kong)
Moderator Yin-Ching Chuang(Taiwan)
14:00-14:25 Long term evidences on homotypic protection of rotavirus vaccine
Jin Han Kang
Professor of pediatric department in The Catholic University of Korea
Senior faculty staff of pediatric infectious diseases in Seoul St. Mary Hospital
The chief Director of The Vaccine Bio Research Institute in The Catholic University of Korea
KOREA
EMB000056a8325b
14:25-14:50 Mechanisms of heterotypic protection of rotavirus vaccine
Philippe Buchy
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Clinical Pathologist and Virologist
SINGAPORE
14:50-15:15 Effectiveness and safety of rotavirus vaccination in the real world
Tony Nelson
Clinical Professional Consultant and Professor of Practice in Paediatrics
Department of Paediatrics
The Chinese University of Hong Kong
HONG KONG
September 5 | 14:00 – 15:30
Session 2B: Hepatitis and Haemophilus influenzae type b vaccine
Moderator Po-Yen Chen (Taiwan)
Moderator Ieong Kin Mui (Macao)
14:00-14:25 Use of combination vaccines containing Haemophilus influenzae b vaccine
Young June Choe
Assistant Professor
Department of Social and Preventive Medicine
Hallym University College of Medicine
KOREA
14:25-14:50 Preventive strategies against hepatitis A and hepatitis E
Po-Yen Chen
Professor, Taichung Veterans General Hospital
TAIWAN
14:50-15:15 Preventive strategies against hepatitis B and hepatitis C
Yen-Hsuan Ni
Dean, National Taiwan Univeresity, College of Medicine
Distinguished Professor of Pediatrics, NTUCM
TAIWAN
September 5 | 15:50 – 17:20
Session 3A: Pneumococcal vaccine
Moderator Somsak Lolekha (Thailand)
Moderator Cheng-Hsun Chiu (Taiwan)
15:50-16:10 Value and impact of protein D conjugation in the PHiD-CV
Michael Nissen
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Infectious Diseases Physician, Paediatrician and Clinical Microbiologist
SINGAPORE
16:10-16:30 Clinical impact of 13-valent pneumococcal conjugate vaccine
Amgad Gamil
Senior Director, Medical & Scientific Affairs Emerging Markets, Vaccines
Emerging Markets, Regional Medical Lead, Asia Region, Vaccines
SINGAPORE
16:30-16:50 Pneumococcal vaccination in Asia
Cheng-Hsun Chiu
Professor, Chang Gung Memorial Hospital
TAIWAN
16:50-17:10 Why multivalent pneumococcal vaccine is needed?
Chun-Yi Lu
Clinical Associate Professor, Department of Pediatrics , National Taiwan University Hospital
TAIWAN
September 5 | 15:50 – 17:20
Session 3B: Measles, mumps, rubella, and polio vaccines
Moderator Nobuhiko Okabe (Japan)
Moderator Nan-Chang Chiu (Taiwan)
15:50-16:15 Efficacy, effectiveness and impact of MMR vaccine
Zo-Ning Huang
Professor, department of pediatrics, MacKay Memorial Hospital
TAIWAN
16:15-16:40 Global resurgence and control strategies of measles and rubella
Nobuhiko Okabe
Director General of Kawasaki City Institute for Public Health, Kawasaki
JAPAN
16:40-17:05 Polio eradication and endgame strategy
Youngmee Jee
Director General, Center for Infectious Disease Research, National Institute of Health
KOREA
September 6 | 08:00 – 09:30
Session 4A: Human papillomavirus vaccine
Moderator Nancy Durand (Canada)
Moderator Luan-Yin Chang (Taiwan)
08:00-08:25 Impact of the ASO4 adjuvanted HPV Vaccine in the Real World
Michael Nissen
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Infectious Diseases Physician, Paediatrician and Clinical Microbiologist
SINGAPORE
08:25-08:50 4-valent and 9-valent HPV vaccines in the real world
Nancy Hughes Durand
Associate Professor, Department of Medicine, University of Toronto
Active Attending Staff, Department of Obstetrics and Gynecology, Sunnybrook Health Science Centre, Toronto, Ontario
CANADA
08:50-09:15 Use of HPV vaccine in the real world: expected and unexpected
Chih-Jung Chen
Professor, Department of Pediatrics, Chang Gung Memorial Hospital
Attending physician in Division of Pediatric Infectious Disease, Department of Pediatric, Chang-Gung Children’s Hospital
TAIWAN
September 6 | 08:00 – 09:30
Session 4B: BCG and Pertussis vaccine
Moderator Zulkifli Ismail (Malaysia)
Moderator Hsin Chi (Taiwan)
08:00-08:25 Updates on the development of tuberculosis vaccines
Pei-Chun Chan
Associated Director, Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and welfare
Medical officer, Division of HIV/AIDS and TB, Centers for Disease Control, Ministry of Health and welfare
Adjunct Attending Physician, Department of Pediatrics, National Taiwan University Children’s Hospital, National Taiwan University, College of Medicine
Adjunct Assistant Professor, Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University
TAIWAN
08:25-08:50 Pertussis: a neglected disease in Asian countries
Zulkifli Ismail
Professor, KPJ Selangor Specialist Hospital
MALAYSIA
08:50-09:15 Effectiveness and safety of pertussis vaccines
Tetsuo Nakayama
Project Professor, Laboratory of Viral Infection II, Kitasato Institute for Life Sciences
JAPAN
September 6 | 09:50 – 11:20
Session 5A: Varicella/Zoster vaccine
Moderator Eun Hwa Choi (Korea)
Moderator TBA
09:50-10:10 Clinical application off varicella vaccine
Patrick Woo
Professor, The University of Hong Kong
HONG KONG
10:10-10:30 Varicella vaccination in NIP program: one dose or two doses?
Eun Hwa Choi
Professor, Pediatric Infectious Diseases, Department of Pediatrics, College of Medicine , Seoul National University
KOREA
10:30-10:50 Importance of adult vaccine & patient engagement of herpes zoster vaccine
Chih-Hsing Wu
Department of Family Medicine, College of Medicine, National Cheng Kung University
TAIWAN
IMG_6774
10:50-11:10 Sub-optimal immunity: value of adjuvanted recombinant zoster vaccine
Philippe Buchy
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Clinical Pathologist and Virologist
SINGAPORE
September 6 | 09:50 – 11:20
Session 5B: Influenza vaccine
Moderator Hoan Jong Lee (Korea)
Moderator Ming-Fang Cheng (Taiwan)
09:50-10:15 Influenza vaccination program in Asia-Pacific region
Hoan Jong Lee
Professor, Department of Pediatrics, Seoul National University (SNU) College of Medicine and Division of Infectious Diseases, Seoul National University Children’s Hospital
KOREA
10:15-10:40 High-dose Influenza vaccine for the elderly
Raina MacIntyre
Professor, Global Biosecurity and Head of the Biosecurity Program at the Kirby Institute, UNSW
AUSTRALIA
10:40-11:05 Adjuvanted influenza vaccine for the elderly
Paul Van Buynder
Public Health Staff Specialist 
Gold Coast Hospital and Health Service
Professor, School of Medicine, Griffith University
AUSTRALIA
September 6 | 11:20 – 12:50
Session 6A: Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium
Moderator Iqbal Memon (Pakistan)
Moderator Ping-Ing Lee (Taiwan)
11:20-11:40 Epidemiology and preventive strategies of pneumococcal diseases in Asia
Daniel Goh
Senior Consultant, Division of Paediatric Pulmonary Medicine and Sleep at the Khoo Teck Puat -National University Children’s Medical Institute, National University Health System
SINGAPORE
11:40-12:00 Barriers to the implementation of pneumococcal conjugate vaccine in children
Lulu Bravo
Professor Emeritus College of Medicine, University of the Philippines Manila
PHILIPPINES
12:00-12:20 Emerging issues after pneumococcal conjugate vaccination programs
Yu-Chia Hsieh
Attending physician, Department of pediatrics, Chang Gung Memorial Hospital
TAIWAN
12:20-12:40 Use of pneumococcal vaccines in the elderly
Sung-Ching Pan
Prof. Department of Internal Medicine, National Taiwan University Hospital
TAIWAN
September 6 | 11:20 – 12:50
Session 6B: New vaccines and vaccine in pipeline
Moderator Nakorn Premsri (Thailand)
Moderator Ching-Chuan Liu (Taiwan)
11:20-11:40 Current development of enterovirus 71 vaccines
Nan-Chang Chiu
Director, Department of Pediatrics, MacKay Children’s Hospital
TAIWAN
11:40-12:00 Enterovirus 71 vaccine in Taiwan
Yea-Huei Shen
Medical and Clinical Operation Director in StatPlus, Inc.
Consultant of Enimmune Corporation
TAIWAN
12:00-12:20 Dengue fever vaccine
Choo Beng Goh
Takeda Vaccines, Asia
SINGAPORE
12:20-12:40 An update on Zika virus vaccines
Anna P. Durbin
Professor, Department of International Health, Johns
Hopkins Bloomberg School of Public Health
USA
September 6 | 13:50 – 15:20
Session 7A: Japanese encephalitis vaccine
Moderator Sanath Punsara Lamabadusuriya (Sri Lanka)
Moderator Ren-Bin Tang (Taiwan)
13:50-14:15 Epidemiology and preventive strategies of JE in Asia
Tomohiki Takasaki
Director General, Kanagawa Prefectural Institute of Public Health
JAPAN
14:15-14:40 Cell-based inactivated JE vaccine
Chih-Hsiang Leng
Director in division of research and development, Adimmune corporation
TAIWAN
14:40-15:05 Live attenuated chimeric JE vaccine
Mong How Ooi
Senior Consultant Paediatrician, Sarawak General Hospital, Kuching, Sarawak, Malaysia
Research Fellow, Institute of Health and Community Medicine, Universiti Malaysia Sarawak (UNIMAS), Malaysia
Adjunct Research Fellow, Brain Infection Group, Institute of Global Health, University of Liverpool, UK
MALAYSIA
September 6 | 13:50 – 15:20
Session 7B: New vaccine technologies
Moderator Michael Nissen (Australia)
Moderator Chun-Yi Lee (Taiwan)
13:50-14:15 New development of bacterial vaccines
Amgad Gamil
Senior Director, Medical & Scientific Affairs Emerging Markets, Vaccines
Emerging Markets, Regional Medical Lead, Asia Region, Vaccines
SINGAPORE
14:15-14:40 New vaccine strategies for classic respiratory diseases: RSV; TB; COPD.
Michael Nissen
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Infectious Diseases Physician, Paediatrician and Clinical Microbiologist
SINGAPORE
14:40-15:05 Modern technology for vaccine development
Philippe Buchy
GSK Vaccines R&D
Director of Scientific Affairs and Public Health
Clinical Pathologist and Virologist
SINGAPORE

Copyright © 2019, MasterClass in Vaccinology, 2020, All Rights Reserved.